Research undertaken by our members @NeuroSimon and @HeatherMortiboy has identified a specific enzyme that impacts glucose metabolism and cell function in Alzheimer’s disease.
Read more about the study:
https://t.co/Z3cBhTQRT9
Had a great time today presenting my work and watching fellow speakers at the dementia futures conference 🧠 It was really inspiring speaking to members of the public / people living with dementia about the current field of work @ARUKYorkshire@ARUKscientist
Well done to @emmafgarland and @hollie_wareing for presenting their work at the dementia futures conference today! Extra well done to @emmafgarland for winning the prize for best presentation 🧬🥼
Well done to our @emmafgarland for attending Bedford Acadey Secondary School for their STEM fest week to talk about what it’s like to be a neuroscientist 🧠 #STEM
Research from @sheffielduni & the UK DRI at Cambridge reveals new insight into how a protein known as apolipoprotein E (APOE) interacts with amyloid-beta, and how this interaction affects the likelihood of developing Alzheimer's👉https://t.co/qQ3LikpSAB
As part of scientists’ efforts to find treatments for Alzheimer’s Disease, they have been investigating the build-up of fat droplets, and their toxicity, in certain brain cells in those diagnosed.
Read @hollie_wareing's summary of what they discovered at https://t.co/g8Sgn908Nw
New lab paper alert 🚨 Published in @NatureComms:
“Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease”
https://t.co/5jwPeketpt
Great work to everyone involved!